"
Template:SupbiotechparisEn
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 62: | Line 62: | ||
[[Team:SupBiotech-Paris/Current therapies|Current therapies]] | [[Team:SupBiotech-Paris/Current therapies|Current therapies]] | ||
[[Team:SupBiotech-Paris/Gene therapies|Gene therapies]] | [[Team:SupBiotech-Paris/Gene therapies|Gene therapies]] | ||
| - | <span style="color: black;">''' | + | <span style="color: black;">'''DVS Concept'''</span> |
[[Team:SupBiotech-Paris/Introduction1|Introduction]] | [[Team:SupBiotech-Paris/Introduction1|Introduction]] | ||
| - | [[Team:SupBiotech-Paris/Concept1| | + | [[Team:SupBiotech-Paris/Concept1|Tissue Vector]] |
| + | [[Team:SupBiotech-Paris/Concept2|Cell Vector]] | ||
| + | [[Team:SupBiotech-Paris/Concept3|Apoptotic plasmid]] | ||
[[Team:SupBiotech-Paris/Conclusion1|Conclusion]] | [[Team:SupBiotech-Paris/Conclusion1|Conclusion]] | ||
| - | |||
| - | |||
| - | |||
| - | |||
<span style="color: black;">'''Implementation'''</span> | <span style="color: black;">'''Implementation'''</span> | ||
[[Team:SupBiotech-Paris/Tissue targeting|Tissue targeting]] | [[Team:SupBiotech-Paris/Tissue targeting|Tissue targeting]] | ||
[[Team:SupBiotech-Paris/Cell targeting|Cell targeting]] | [[Team:SupBiotech-Paris/Cell targeting|Cell targeting]] | ||
| - | [[Team:SupBiotech-Paris/Modification| | + | [[Team:SupBiotech-Paris/Modification|Cancer Modelisation]] |
[[Team:SupBiotech-Paris/Conclusion3|Conclusion]] | [[Team:SupBiotech-Paris/Conclusion3|Conclusion]] | ||
Revision as of 11:54, 21 September 2009
Project
Introduction Current therapies Gene therapies DVS Concept Introduction Tissue Vector Cell Vector Apoptotic plasmid Conclusion Implementation Tissue targeting Cell targeting Cancer Modelisation Conclusion
Ressources
Biobricks Material & Method Bibliography
Ethic & Safety
Synthetic Biology Our project Safety
